Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

272.70 USD -2.84 (-1.03%)
Streaming Delayed Price Updated: 10:54 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Shares of Biogen Inc Down on Above Average Volume, Moving Against Trend (BIIB)
Biogen Inc's stock is down 10.8% to $293.40 on heavy trading volume. Today's volume of 3.0 million shares tops the average 30-day volume of 2.4 million shares. Unusually... 
From Comtex SmarTrend® News Briefs
Noteworthy ETF Inflows: IBB, VRTX, BIIB, REGN
Symbols mentioned in this story: IBB, VRTX, BIIB, REGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
UPDATE 2-Biogen delays Alzheimer's drug filing plans, shares fall 11%
Biogen Inc on Wednesday delayed the filing for marketing approval of its experimental Alzheimer's disease drug, saying that it needed more time to prepare the data before submission. 
Tags companyNews
From Reuters: Company News
Nasdaq 100 Movers: BIIB, LRCX
In early trading on Wednesday, shares of Lam Research topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.7%. Year to date, Lam Research has lost about 10.3%... 
Tags Stocks
From Market News Video
S&P 500 Movers: BIIB, EXPE
In early trading on Wednesday, shares of Expedia Group topped the list of the day's best performing components of the S&P 500 index, trading up 8.0%. Year to date, Expedia Group has lost about 42.8% of... 
Tags Stocks
From Market News Video
Dow Jones Today Poised To Bounce As Oil Prices Wobble; Netflix Dives, Facebook Takes A Stake In India
BioNTech soared, Pfizer led the Dow Jones today on vaccine news, as oil prices sought equilibirum amid the coronavirus pandemic. 
From Investor's Business Daily
UPDATE 1-Biogen delays Alzheimer's drug filing plans, shares fall
Biogen Inc said on Wednesday it would delay filing for marketing approval of its much-awaited experimental Alzheimer's disease drug to the third quarter, sending its shares down 7%. 
Tags companyNews
From Reuters: Company News
Biogen Earnings Easily Beat Views, But Biotech Giant Falls
Biogen earnings easily topped Q1 2020 views. The biotech company's revenue also topped. Biogen stock fell but has been nearing a buy point. 
From Investor's Business Daily
Biogen posts marginal rise in first-quarter sales
Biogen Inc posted a 1.3% rise in first-quarter sales on Wednesday, helped by demand for its spinal muscular atrophy drug as well as its multiple sclerosis treatment, Tecfidera. 
Tags companyNews
From Reuters: Company News
Dow futures cling to slight gains with earnings from Delta, Biogen and AT&T on deck
U.S. stock-index futures on Tuesday struggled for direction, and were up slightly at last check, in thinly traded action, after the broader market finished at about the lowest level in about two weeks,... 
Tags SNAP NFLX Markets/Exchanges
From MarketWatch
Dow Jones Futures: Crashing Crude Oil Prices Test Coronavirus Stock Market Rally; Netflix, Snap, Chipotle, Texas Instruments Are Key Earnings Movers After Microsoft, Nvidia, Apple, Tesla Sell Off
Crashing crude oil prices are testing the coronavirus stock market rally and breakouts. Netflix, Snap, Chipotle were earnings movers overnight. 
From Investor's Business Daily
First Airline Earnings Due Since Covid-19 Bailouts: Investing Action Plan
Delta Air Lines reports Tuesday, marking the first airlines earnings since the industry received billions in government bailout money. 
From Investor's Business Daily
Earnings In The Time Of Corona: Why Gilead, Vertex Could Outperform
Gilead Sciences and Vertex Pharmaceuticals are the best-positioned biotech companies heading into the first-quarter earnings season, SVB Leerink analyst Geoffrey Porges suggested Monday. 
From Investor's Business Daily
The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision
Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17. Apart from the broader market ... 
Tags NURO coronavirus MMSI
From Benzinga
Coronavirus creates a market of ‘haves and have-nots,’ with the Dow posting its best 2-week run in 82 years amid 22 million job losses
Shall the last turn out to be first? That is essentially the question that Wall Street may be considering in a market that is attempting to stage a lasting rebound after being shocked lower by the... 
Tags KO T DE:CTX
From MarketWatch
Biogen Is Building a COVID-19 Biobank With the Broad Institute
A consortium in Cambridge, Massachusetts, will test patients who have recovered from the coronavirus to advance the search for vaccines and treatments. 
Tags Market News BIIB
From Motley Fool
Which Stocks Will Be The Big COVID-19 Winners?
It’s natural during a crisis… Investors want to find the companies that will help solve the problem and come out as big winners. The company or companies that do produce effective treatments and... 
Tags Stocks / Equities
From Blogs - TalkMarkets
UPDATE 1-Biogen joins consortium for building COVID-19 'biobank'
Biogen Inc said on Thursday it had joined a consortium to build a collection of biological and medical data, where its employees who had tested for and recovered from the coronavirus would be able to... 
Tags companyNews
From Reuters: Company News
Biogen joins consortium for building COVID-19 'biobank'
Biogen Inc said on Thursday it had joined a consortium to build a collection of biological and medical data, where its employees who had tested and recovered from the coronavirus would be able to... 
Tags companyNews
From Reuters: Company News
Every Member Of Trump's 'Great American Economic Revival' Industry Groups
President Donald Trump annnounced a lengthy list of "Great American Economic Revival" industry groups Tuesday that he said ... 
Tags NCLH UBER GD
From Benzinga
The biggest stock-market lesson from the last 12 months: Stay calm
In times like these, a longer-term perspective can help. While the S&P 500 is down 2% over the past year, the tech sector has climbed 16%. Here are the big winners. 
Tags DG ANSS JD
From MarketWatch
Goldman Sachs abandons its bearish near-term view on stocks, says the bottom is in
Our call of the day comes from Goldman Sachs, which says it no longer thinks the S&P 500 could be headed for 2,000 in the near term. 
Tags Market News JP:NIK Pharmaceuticals
From MarketWatch
Better Buy: Alnylam Pharmaceuticals vs. Vir Biotechnology
Will a 14-year head start prove to be an advantage between these biotechs? 
Tags Market News ALNY VIR
From Motley Fool
Should Investors Take a Chance on Biogen?
Despite Biogen successfully fending off patent challenges to its top-selling product, the company's future remains murky. 
Tags BIIB NVS VIR
From Motley Fool
These stocks rose the most Wednesday, as laggards from previous trading sessions bounced back
The S&P 500 Index was buoyed by the real estate, energy and utilities sectors. 
Tags WMT INTC TDG
From MarketWatch
Healthcare Outperforms After Sanders Ends Bid For Democratic Nomination
Shares of healthcare-related stocks are outperforming a strong move in the broader market on Wednesday. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing
An investor's guide to healthcare companies' coronavirus efforts. 
Tags BMXMF MRNA BDX
From Motley Fool
UPDATE 2-GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential antibody treatments for COVID-19, the disease caused by the new coronavirus, the... 
Tags companyNews
From Reuters: Company News
CORRECTED-UPDATE 1-GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the... 
Tags companyNews
From Reuters: Company News
UPDATE 1-GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the... 
Tags companyNews
From Reuters: Company News
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.